Related content

Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43°C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients

By Elias Dominique   Goere Diane   Blot François   Billard Valérie   Pocard Marc   Kohneh-Shahri Niaz   Raynard Bruno  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1818-1824

Springer Publishing Company

Access to resources Recommend Favorite

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

By Blackham Aaron  

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2720-2727

Springer Publishing Company

Access to resources Recommend Favorite

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin

By Witkamp A.J.   de Bree E.   Kaag M.M.   Boot H.   Beijnen J.H.   van Slooten G.W.   van Coevorden F.   Zoetmulder F.A.N.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 979-984

Elsevier

Access to resources Recommend Favorite

Closed Abdomen Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Mitomycin C: a Phase I Study

By Cotte Eddy   Passot Guillaume   Tod Michel   Bakrin Naoual   Gilly François-Noël   Steghens Aline   Mohamed Faheez   Glehen Olivier  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2599-2603

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy

By Tuttle Todd   Zhang Yan   Greeno Edward   Knutsen Amy  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1627-1632

Springer Publishing Company

Access to resources Recommend Favorite